Literature DB >> 28387881

REVIEW-ARTICLE Intermediate alleles of Huntington's disease HTT gene in different populations worldwide: a systematic review.

T A Apolinário1, C L A Paiva1,2,3, L A Agostinho4,5,6,7.   

Abstract

Huntington's disease (HD) is an autosomal dominant progressive neurodegenerative disorder caused by a dynamic mutation due to the expansion of CAG repeats in the HTT gene (4p16.3). The considered normal alleles have less than 27 CAG repeats. Intermediate alleles (IAs) show 27 to 35 CAG repeats and expanded alleles have more than 35 repeats. The IAs apparently have shown a normal phenotype. However, there are some reported associations between individuals that bear an IA and clinical HD signs, such as behavioral disturbs. The association of IAs with the presence of clinical signs gives clinical relevance to these patients. We emphasized the importance of determining the frequency of IA alleles in the general population as well as in HD families. Therefore, the aim of this study was to conduct a systematic review, in order to investigate the frequency of IAs in the overall chromosomes of different ethnic groups and of families with HD history worldwide as well as the frequency of individuals who bear the intermediate alleles. We searched indexed articles from the following electronic databases: U.S. National Library of Medicine and the National Institutes of Health (PubMed), Pubmed Central (PMC) and Virtual Health Library (VHL). Therefore, 488 articles were obtained and, of these, 33 had been published in more than one database. We accepted the article of only one database and ended up with 455 articles for this review. The frequency of IAs within the chromosomes of the general population ranged from 0.45 to 8.7% and of individuals with family history of HD ranged from 0.05 to 5.1%. The higher frequency of IAs in the general population (8.7%) was found in one Brazilian cohort.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28387881     DOI: 10.4238/gmr16029648

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  7 in total

Review 1.  Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases.

Authors:  Jonah Doustar; Tania Torbati; Keith L Black; Yosef Koronyo; Maya Koronyo-Hamaoui
Journal:  Front Neurol       Date:  2017-12-19       Impact factor: 4.003

Review 2.  Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases.

Authors:  Federica Ciregia; Andrea Urbani; Giuseppe Palmisano
Journal:  Front Mol Neurosci       Date:  2017-08-31       Impact factor: 5.639

3.  Incidence of Huntington disease in a northeastern Spanish region: a 13-year retrospective study at tertiary care centre.

Authors:  Paula Sienes Bailo; Raquel Lahoz; Juan Pelegrín Sánchez Marín; Silvia Izquierdo Álvarez
Journal:  BMC Med Genet       Date:  2020-11-23       Impact factor: 2.103

4.  Genetic epidemiological characteristics of a Hungarian subpopulation of patients with Huntington's disease.

Authors:  Katalin Despotov; Dénes Zádori; Gábor Veres; Katalin Jakab; Gabriella Gárdián; Eszter Tóth; Tamás Zsigmond Kincses; László Vécsei; András Ajtay; Dániel Bereczki; Péter Klivényi
Journal:  BMC Neurol       Date:  2021-02-18       Impact factor: 2.474

5.  High frequency of intermediary alleles in the HTT gene in Northern Sweden - The Swedish Huntingtin Alleles and Phenotype (SHAPE) study.

Authors:  Jimmy Sundblom; Valter Niemelä; Maria Ghazarian; Ann-Sofi Strand; Ingvar A Bergdahl; Jan-Håkan Jansson; Stefan Söderberg; Eva-Lena Stattin
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.996

6.  Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease-affected families.

Authors:  Thays A Apolinário; Iane Dos Santos da Silva; Luciana de Andrade Agostinho; Carmen L A Paiva
Journal:  Mol Genet Genomic Med       Date:  2020-02-17       Impact factor: 2.183

7.  Brain Microbiota in Huntington's Disease Patients.

Authors:  Ruth Alonso; Diana Pisa; Luis Carrasco
Journal:  Front Microbiol       Date:  2019-11-12       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.